Prostate, Phase III
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Volunteers
Health Professionals
What is the purpose of this trial?
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Abhijit Patel, MD, PhD
- Agatha Hecht
- Alessia Donadio, MD
- Andrea Martelli
- Armand Russo, MD
- Ashita Talsania, MRCP, MBBS
- Bruce A. McGibbon, MD
- Daniel P. Petrylak, MD
- David Witt, MD
- Elan Gorshein, DO, JD, MPH
- Hari Deshpande, MD
- Harold Tara Jr, MD
- Henry S. Park, MD, MPH
- James Vredenburgh, MD
- James E. Hansen, MD, MS
- Jane Kanowitz, MD
- Jason Haldas, MD
- Jaykumar Thumar, MBBS, MD
- Jeremy Kortmansky, MD
- John Glendening
- Joseph Kim, MD
- Justin Persico, MD
- Karishma Mehra, MBBS
- Katherine Harvey, MD, MPH
- Kenneth B. Roberts, MD
- Kert Sabbath, MD, FACP
- Kimberly L. Johung, MD, PhD
- Kristen Hoxie
- Madeline Santiago
- Meena S. Moran, MD
- Melissa Rasar Young, MD, PhD
- Michael Cohenuram, MD
- Michael Hurwitz, MD, PhD
- Neal Fischbach, MD
- Pawan Karanam, MD
- Roy H. Decker, MD/PhD
- Stephen Lattanzi, MD
- Su Hsien Lim, MD
- Victor Chang, MD
- Virginia Syombathy
- Wajih Kidwai, MD, FACP
- Yi An, MD
- Last Updated08/11/2023
- Study HIC#2000025125